Zotefoams PLC
22 November 2005
Zotefoams plc ('the Company')
Directors' Shareholdings
The Company was notified on 21 November 2005 that Mr Clifford Hurst and Mr David
Stirling, both directors of the Company, have each exercised 12,337 options
under the Company's SAYE scheme at an exercise price of 77p per ordinary 5p
share ('Ordinary Share'). Following this exercise of options, Mr Hurst and Mr
Stirling have an interest in 37,366 and 40,962 Ordinary Shares respectively,
representing 0.1% per cent. and 0.1% per cent. respectively, of the Company's
issued Ordinary Share capital.
In addition, Mr Hurst and Mr Stirling hold the following options over Ordinary
Shares:
Mr D Stirling
Number of options Exercise period Exercise price Option scheme
246,280 07.04.2007 to 06.04.2014 72.5p Executive
210,093 20.08.2005 to 19.08.2012 80.5p Executive
217,748 18.3.2006 to 17.3.2013 80.0p Executive
37,500 18.3.2006 to 17.3.2013 80.0p Inland Revenue
Approved
Mr C Hurst
Number of options Exercise period Exercise price Option scheme
41,379 07.04.2007 to 06.04.2014 72.5p Inland Revenue
Approved
178,895 07.04.2007 to 06.04.2014 72.5p Executive
148,975 20.08.2005 to 19.08.2012 80.5p Executive
154,403 18.3.2006 to 17.3.2013 80.0p Executive
22 November 2005
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.